- Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal Bloomberg
- Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal The Hindu
- AZB, White & Case, CAM, Sullivan & Cromwell act on Organon’s acquisition by Sun Pharma USA ETLegalWorld.com
- White & Case, AZB, Sullivan, Cyril Amarchand Mangaldas act on Sun Pharma’s $11.75 billion acquisition of Organon Bar and Bench
- Sun Pharma shares jump over 7% after firm announces plan to acquire US-based Organon at $11.75 billion valuation Upstox